Genomic alterations of WT1 including point mutations and small insertions and deletions have been reported in 5% of AML cases [2,43] and the haploinsufficiency of PUF60 has been associated with the progression of T-ALL in a mouse model with homozygous deletion of TP53 [20]. This evidence concerns the gene WT1 and acute myeloid leukemia.